AIMT
Aimmune Therapeutics
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
58 hedge funds and large institutions have $551M invested in Aimmune Therapeutics in 2015 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
1 | +$154M | |
2 | +$104M | |
3 | +$71.4M | |
4 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
+$31.4M |
5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$25.2M |
Top Sellers
No sellers this quarter